The Medical Letter on Drugs and Therapeutics
FROM
ISSUE879
ISSUE879
September 18, 1992
Loracarbef
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Loracarbef
September 18, 1992 (Issue: 879)
Loracarbef (Lorabid - Lilly), a new beta-lactam antibiotic with antimicrobial activity similar to the second-generation cephalosporins, has been approved by the US Food and Drug Administration for treatment of respiratory, skin, and urinary tract...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.